Dr. Takeda receives Astellas Foundation Metabolic Disorders Research Grant
Dr. Kojiro Takeda, Group Leader of the G0 Cell Unit, has been granted FY2010 research funding from Astellas Foundation for Research on Metabolic Disorders. This grant is awarded for research on the elucidation of disease processes and the development of ground-breaking medical treatments.
The title of Dr. Takeda’s research proposal is: “Cooperative roles of the proteasome and autophagy for mitochondrial maintenance and life span in the quiescent phase of fission yeast. “ Using fission yeast as a model organism, he aims to deepen the understanding of mechanisms for maintaining the function and survivability of cells arrested at G0 phase (cellular quiescence), where cells cease proliferation. Outcomes of this research are expected to contribute to the development of treatment for neurodegenerative diseases including Parkinson’s disease and metabolic syndrome such as diabetes.
Dr. Takeda is one of the grantees selected from a total of 542 applicants. According to the Astellas Foundation for Research on Metabolic Disorders, he is the first scientist conducting research in
Summary of Dr. Takeda’s research proposal
For press inquiries, please contact email@example.com.